Cost-effectiveness of secukinumab compared with ustekinumab and etanercept for the treatment of moderate-to-severe plaque psoriasis in Greece

被引：0

作者：

Tzanetakos, C. ^{[1
]}

Kourlaba, G. ^{[2
]}

Hatzikou, M. ^{[3
]}

Antoniou, C. ^{[4
]}

Ioannides, D. ^{[5
]}

Lefaki, I. ^{[6
]}

Petridis, A. ^{[7
]}

Rigopoulos, D. ^{[8
]}

Roussaki-Schulze, V. ^{[9
]}

Sotiriadis, D. ^{[10
]}

Maniadakis, N. ^{[1
]}

机构：

[1] Natl Sch Publ Hlth, Hlth Serv Org & Management, Athens, Greece

[2] Aghia Sophia Childrens Hosp, Collaborat Ctr Clin Epidemiol & Outcomes Res CLEO, Athens, Greece

[3] Novartis Hellas SACI SA, Athens, Greece

[4] Univ Athens, Hosp Venereol Dermatol Dis A Syggros, Athens, Greece

[5] Aristoteleio Univ Thessaloniki, Hosp Skin & Venereal Dis, Thessaloniki, Greece

[6] Hosp Skin & Venereal Dis, Dermatol Clin, Thessaloniki, Greece

[7] Hosp Venereol Dermatol Dis A Syggros, Dermatol Clin, Athens, Greece

[8] Univ Athens, Attikon Univ Hosp Athens, Athens, Greece

[9] Univ Thessaly, Univ Hosp Larissa, Larisa, Greece

[10] Aristoteleio Univ Thessaloniki, Gen Hosp Thessaloniki PAPAGEORGIOU, Thessaloniki, Greece

来源：

关键词：

cost-effectiveness; plaque psoriasis; secukinumab;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P125

引用

页码：61 / 62

页数：2